Nutra Pharma Signs Definitive Letter of Intent for $4 Million Joint Venture Financing
Contact: Nutra Pharma Corp. Nina Goldstein 877-895-5647 IR@nutrapharma.com Nutra Pharma is announcing the execution of a Letter of Intent for a $4 Million financing to fund a joint venture for the marketing and distribution of the Company’s Over-the-Counter products. June 28, 2018 -- Coral Springs, Florida -- Nutra Pharma Corporation(OTC: NPHC), a biotechnology company marketing Nyloxin®and Pet Pain-Away™in the over-the-counter (OTC) pain management marketand which is also de
Nutra Pharma Announces Direct Response Television Campaign for Pet Pain-Away™
Contact: Nutra Pharma Corp. Nina Goldstein 877-895-5647 IR@nutrapharma.com Nutra Pharma is announcing the next phase of marketing their Over-the-Counter (OTC) pain reliever for dogs and cats, Pet Pain-Away™ through their direct response partner, DEG Productions. June 6, 2018 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced today that